title: Prognostic factors and treatment of myelodysplastic syndromes.
authors.affiliation: Institute of Hematology, University Clinical Centre and Medical Faculty, Belgrade, Yugoslavia.
authors.forename: A
authors.initials: A
authors.lastname: Mijović
authors.forename: D
authors.initials: D
authors.lastname: Bosković
authors.forename: I
authors.initials: I
authors.lastname: Elezović
authors.forename: D
authors.initials: D
authors.lastname: Tomin
authors.forename: M
authors.initials: M
authors.lastname: Gotić
authors.forename: S
authors.initials: S
authors.lastname: Janosević
authors.forename: Z
authors.initials: Z
authors.lastname: Rolović
mesh_terms: D000368:Aged; D000469:Alkaline Phosphatase / Q000097:blood; D003561:Cytarabine / Q000008:administration & dosage; D005260:Female; D006801:Humans; D007962:Leukocytes / Q000201:enzymology; D008297:Male; D008875:Middle Aged; D009190:Myelodysplastic Syndromes / Q000145:classification* / Q000188:drug therapy / Q000201:enzymology; D011379:Prognosis; D016032:Randomized Controlled Trials as Topic
chemical_list: D003561:Cytarabine; D000469:Alkaline Phosphatase